Incannex Healthcare Statistics
Total Valuation
IXHL has a market cap or net worth of $36.50 million. The enterprise value is $27.30 million.
| Market Cap | 36.50M |
| Enterprise Value | 27.30M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
IXHL has 15.87 million shares outstanding. The number of shares has increased by 31.34% in one year.
| Shares Outstanding | 15.87M |
| Shares Change (YoY) | +31.34% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 21.54% |
| Owned by Institutions (%) | 6.39% |
| Float | 12.79M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.96 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.70, with a Debt / Equity ratio of 0.02.
| Current Ratio | 6.70 |
| Quick Ratio | n/a |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -30.90% and return on invested capital (ROIC) is -127.02%.
| Return on Equity (ROE) | -30.90% |
| Return on Assets (ROA) | -29.60% |
| Return on Capital (ROIC) | -127.02% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.74M |
| Employee Count | 10 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (1Y) | 2.27 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 3.64 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 33.69 |
| Average Volume (30 Days) | 322,232 |
Short Selling Information
The latest short interest is 41,800, so 0.26% of the outstanding shares have been sold short.
| Short Interest | 41,800 |
| Short Previous Month | 89,191 |
| Short % of Shares Out | 0.26% |
| Short % of Float | 0.33% |
| Short Ratio (days to cover) | 0.50 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -16.05M |
| Pretax Income | -11.38M |
| Net Income | -17.42M |
| EBITDA | n/a |
| EBIT | -11.38M |
| Earnings Per Share (EPS) | -$0.70 |
Balance Sheet
The company has $9.51 million in cash and $307,055 in debt, giving a net cash position of $9.20 million or $0.58 per share.
| Cash & Cash Equivalents | 9.51M |
| Total Debt | 307,055 |
| Net Cash | 9.20M |
| Net Cash Per Share | $0.58 |
| Equity / Book Value | 12.33M |
| Book Value Per Share | 0.78 |
| Working Capital | 11.85M |
Cash Flow
In the last 12 months, operating cash flow was -$10.24 million and capital expenditures -$386,124, giving a free cash flow of -$10.63 million.
| Operating Cash Flow | -10.24M |
| Capital Expenditures | -386,124 |
| Free Cash Flow | -10.63M |
| FCF Per Share | -$0.67 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
IXHL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -31.34% |
| Shareholder Yield | -31.34% |
| Earnings Yield | -47.72% |
| FCF Yield | -29.12% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on November 30, 2023. It was a reverse split with a ratio of 1:4.
| Last Split Date | Nov 30, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:4 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |